Vanguard Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,914,315
Closed -$18.6M 4272
2020
Q3
$18.6M Sell
5,914,315
-53,222
-0.9% -$168K ﹤0.01% 2493
2020
Q2
$17.4M Buy
5,967,537
+339,548
+6% +$988K ﹤0.01% 2489
2020
Q1
$15.9M Buy
5,627,989
+104,037
+2% +$293K ﹤0.01% 2394
2019
Q4
$17.9M Sell
5,523,952
-717,192
-11% -$2.33M ﹤0.01% 2582
2019
Q3
$13.5M Sell
6,241,144
-3,085,747
-33% -$6.66M ﹤0.01% 2670
2019
Q2
$29.3M Sell
9,326,891
-1,304,470
-12% -$4.1M ﹤0.01% 2348
2019
Q1
$39.5M Buy
10,631,361
+551,973
+5% +$2.05M ﹤0.01% 2203
2018
Q4
$29.2M Sell
10,079,388
-388,137
-4% -$1.13M ﹤0.01% 2274
2018
Q3
$27.5M Sell
10,467,525
-2,711,435
-21% -$7.13M ﹤0.01% 2430
2018
Q2
$30.8M Buy
13,178,960
+648,092
+5% +$1.52M ﹤0.01% 2368
2018
Q1
$36.8M Sell
12,530,868
-424,333
-3% -$1.25M ﹤0.01% 2223
2017
Q4
$35.5M Buy
12,955,201
+491,368
+4% +$1.35M ﹤0.01% 2234
2017
Q3
$42.3M Sell
12,463,833
-406,628
-3% -$1.38M ﹤0.01% 2120
2017
Q2
$31.8M Sell
12,870,461
-1,309,657
-9% -$3.23M ﹤0.01% 2250
2017
Q1
$32.2M Buy
14,180,118
+827,830
+6% +$1.88M ﹤0.01% 2204
2016
Q4
$28.3M Sell
13,352,288
-164,442
-1% -$349K ﹤0.01% 2251
2016
Q3
$45.3M Buy
13,516,730
+2,117,287
+19% +$7.09M ﹤0.01% 1975
2016
Q2
$35.8M Buy
11,399,443
+561,405
+5% +$1.76M ﹤0.01% 2045
2016
Q1
$36.1M Sell
10,838,038
-360,230
-3% -$1.2M ﹤0.01% 2019
2015
Q4
$39.6M Buy
11,198,268
+82,012
+0.7% +$290K ﹤0.01% 1993
2015
Q3
$55.9M Sell
11,116,256
-115,982
-1% -$583K ﹤0.01% 1801
2015
Q2
$72.2M Sell
11,232,238
-289,136
-3% -$1.86M ﹤0.01% 1742
2015
Q1
$81.1M Buy
11,521,374
+266,961
+2% +$1.88M 0.01% 1649
2014
Q4
$86.8M Buy
11,254,413
+923,687
+9% +$7.12M 0.01% 1513
2014
Q3
$77.2M Buy
10,330,726
+161,020
+2% +$1.2M 0.01% 1539
2014
Q2
$98.4M Buy
10,169,706
+212,229
+2% +$2.05M 0.01% 1409
2014
Q1
$82.7M Buy
9,957,477
+1,219,176
+14% +$10.1M 0.01% 1473
2013
Q4
$73.8M Buy
8,738,301
+85,315
+1% +$720K 0.01% 1524
2013
Q3
$69M Buy
8,652,986
+583,352
+7% +$4.65M 0.01% 1503
2013
Q2
$62.3M Buy
+8,069,634
New +$62.3M 0.01% 1478